Related Experiment Videos
Experimental models of accelerated atherosclerosis syndromes
D Mehta1, G D Angelini, A J Bryan
1Bristol Heart Institute, University of Bristol, UK.
Abstract:
The processes of angioplasty restenosis, vein graft failure, and transplant atherosclerosis, collectively termed 'syndromes of accelerated atherosclerosis', have been the focus of significant clinical and experimental research. Limitations of clinical studies have forced emphasis onto experimental animal models for the purpose of determining pathophysiology and evaluation of potential therapeutic strategies. However, the apparent failure of many in vivo animal models to predict interventional outcome in humans has raised doubt over their suitability as models of these pathophysiological states. Similar criticism has befallen the use of in vitro techniques for elucidating pathophysiology of the cellular elements. An awareness of the shortcomings of the various experimental models in use would therefore seem prerequisite both to a more critical evaluation of data generated from their use, and to the development of truly effective therapeutic strategies for humans.
Insights
Experimental models for accelerated atherosclerosis, including animal and in vitro studies, often fail to predict human outcomes. Understanding these limitations is crucial for developing effective therapies for conditions like restenosis and graft failure.
Area of Science:
- Cardiovascular Research
- Translational Medicine
- Atherosclerosis Pathophysiology
Background:
- Syndromes of accelerated atherosclerosis, including restenosis, vein graft failure, and transplant atherosclerosis, are significant clinical challenges.
- Clinical studies are limited, necessitating reliance on experimental models for research.
- Existing experimental models face challenges in accurately predicting human outcomes.
Purpose of the Study:
- To review the limitations of current experimental models used to study accelerated atherosclerosis.
- To emphasize the need for critical evaluation of data from these models.
- To guide the development of more effective therapeutic strategies for human patients.
Main Methods:
- Review of existing literature on in vivo animal models and in vitro techniques.
- Analysis of the predictive value of experimental models in human interventional outcomes.
- Discussion of the shortcomings of current experimental approaches.
Main Results:
- Many in vivo animal models demonstrate poor predictability for human interventional outcomes in accelerated atherosclerosis.
- In vitro techniques also face criticism regarding their ability to fully elucidate cellular pathophysiology.
- A significant gap exists between experimental model findings and human clinical relevance.
Conclusions:
- Awareness of experimental model limitations is essential for accurate data interpretation.
- Improved experimental models are needed for the development of effective human therapies.
- Critical evaluation of model suitability is prerequisite for advancing research in accelerated atherosclerosis.